サマリー

mTOR阻害剤は、mTOR（mechanistic target of rapamycin）を阻害する薬剤の一種である。
市場の分析と洞察。mTOR阻害剤の世界市場
COVID-19の流行により、mTOR阻害剤の世界市場規模は2022年に百万米ドル相当と推定され、レビュー期間中にCAGR %で2028年までに百万米ドルに再調整されると予測されています。この健康危機による経済変化を十分に考慮し、2021年にmTOR阻害剤世界市場の％を占めたラパミュンは、2028年までに百万米ドルの価値を持ち、COVID-19後の期間に修正された％のCAGRで成長すると予測されます。一方、腫瘍治療セグメントは、この予測期間を通じて、CAGRに変更されています。
哺乳類ラパマイシン標的（mTOR）阻害剤は、哺乳類ラパマイシン標的の活性をブロックする。哺乳類ラパマイシン標的はプロテインキナーゼであり、細胞増殖や血管新生を刺激する成長因子を制御しています。ある種のがんでは、mTOR経路がより活性化されています。

世界のmTOR阻害剤の範囲とセグメント
mTOR阻害剤市場は、タイプ別および用途別に分類されます。mTOR阻害剤の世界市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるようになるでしょう。セグメント別分析では、2017年から2028年までのタイプ別およびアプリケーション別の売上、収益、予測に焦点を当てています。

タイプ別セグメント
ラパムーン
トーリセル
アフィニトール
ゾートレス
用途別セグメント
腫瘍治療
腎臓移植
その他
会社別
LCラボラトリーズ
テバ・ファーマシューティカル・インダストリーズ社
エクセリクシス
ノバルティス オンコロジー
ファイザー
GSK
地域別
北米
米国
カナダ
メキシコ
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
インドネシア
タイ
マレーシア
フィリピン
ベトナム
中南米
ブラジル
中東・アフリカ
トルコ
GCC諸国
エジプト
南アフリカ

ページTOPに戻る

目次

1 Study Coverage
1.1 mTOR Inhibitors Product Introduction
1.2 Market by Type
1.2.1 Global mTOR Inhibitors Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Rapamune
1.2.3 Torisel
1.2.4 Afinitor
1.2.5 Zortress
1.3 Market by Application
1.3.1 Global mTOR Inhibitors Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Tumor Treatment
1.3.3 Kidney Transplant
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global mTOR Inhibitors Sales Estimates and Forecasts 2017-2028
2.2 Global mTOR Inhibitors Revenue Estimates and Forecasts 2017-2028
2.3 Global mTOR Inhibitors Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global mTOR Inhibitors Sales by Region
2.4.1 Global mTOR Inhibitors Sales by Region (2017-2022)
2.4.2 Global Sales mTOR Inhibitors by Region (2023-2028)
2.5 Global mTOR Inhibitors Revenue by Region
2.5.1 Global mTOR Inhibitors Revenue by Region (2017-2022)
2.5.2 Global mTOR Inhibitors Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global mTOR Inhibitors Sales by Manufacturers
3.1.1 Global Top mTOR Inhibitors Manufacturers by Sales (2017-2022)
3.1.2 Global mTOR Inhibitors Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of mTOR Inhibitors in 2021
3.2 Global mTOR Inhibitors Revenue by Manufacturers
3.2.1 Global mTOR Inhibitors Revenue by Manufacturers (2017-2022)
3.2.2 Global mTOR Inhibitors Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by mTOR Inhibitors Revenue in 2021
3.3 Global mTOR Inhibitors Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global mTOR Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global mTOR Inhibitors Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global mTOR Inhibitors Sales by Type
4.1.1 Global mTOR Inhibitors Historical Sales by Type (2017-2022)
4.1.2 Global mTOR Inhibitors Forecasted Sales by Type (2023-2028)
4.1.3 Global mTOR Inhibitors Sales Market Share by Type (2017-2028)
4.2 Global mTOR Inhibitors Revenue by Type
4.2.1 Global mTOR Inhibitors Historical Revenue by Type (2017-2022)
4.2.2 Global mTOR Inhibitors Forecasted Revenue by Type (2023-2028)
4.2.3 Global mTOR Inhibitors Revenue Market Share by Type (2017-2028)
4.3 Global mTOR Inhibitors Price by Type
4.3.1 Global mTOR Inhibitors Price by Type (2017-2022)
4.3.2 Global mTOR Inhibitors Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global mTOR Inhibitors Sales by Application
5.1.1 Global mTOR Inhibitors Historical Sales by Application (2017-2022)
5.1.2 Global mTOR Inhibitors Forecasted Sales by Application (2023-2028)
5.1.3 Global mTOR Inhibitors Sales Market Share by Application (2017-2028)
5.2 Global mTOR Inhibitors Revenue by Application
5.2.1 Global mTOR Inhibitors Historical Revenue by Application (2017-2022)
5.2.2 Global mTOR Inhibitors Forecasted Revenue by Application (2023-2028)
5.2.3 Global mTOR Inhibitors Revenue Market Share by Application (2017-2028)
5.3 Global mTOR Inhibitors Price by Application
5.3.1 Global mTOR Inhibitors Price by Application (2017-2022)
5.3.2 Global mTOR Inhibitors Price Forecast by Application (2023-2028)
6 North America
6.1 North America mTOR Inhibitors Market Size by Type
6.1.1 North America mTOR Inhibitors Sales by Type (2017-2028)
6.1.2 North America mTOR Inhibitors Revenue by Type (2017-2028)
6.2 North America mTOR Inhibitors Market Size by Application
6.2.1 North America mTOR Inhibitors Sales by Application (2017-2028)
6.2.2 North America mTOR Inhibitors Revenue by Application (2017-2028)
6.3 North America mTOR Inhibitors Market Size by Country
6.3.1 North America mTOR Inhibitors Sales by Country (2017-2028)
6.3.2 North America mTOR Inhibitors Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
6.3.5 Mexico
7 Europe
7.1 Europe mTOR Inhibitors Market Size by Type
7.1.1 Europe mTOR Inhibitors Sales by Type (2017-2028)
7.1.2 Europe mTOR Inhibitors Revenue by Type (2017-2028)
7.2 Europe mTOR Inhibitors Market Size by Application
7.2.1 Europe mTOR Inhibitors Sales by Application (2017-2028)
7.2.2 Europe mTOR Inhibitors Revenue by Application (2017-2028)
7.3 Europe mTOR Inhibitors Market Size by Country
7.3.1 Europe mTOR Inhibitors Sales by Country (2017-2028)
7.3.2 Europe mTOR Inhibitors Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 UK
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific mTOR Inhibitors Market Size by Type
8.1.1 Asia Pacific mTOR Inhibitors Sales by Type (2017-2028)
8.1.2 Asia Pacific mTOR Inhibitors Revenue by Type (2017-2028)
8.2 Asia Pacific mTOR Inhibitors Market Size by Application
8.2.1 Asia Pacific mTOR Inhibitors Sales by Application (2017-2028)
8.2.2 Asia Pacific mTOR Inhibitors Revenue by Application (2017-2028)
8.3 Asia Pacific mTOR Inhibitors Market Size by Region
8.3.1 Asia Pacific mTOR Inhibitors Sales by Region (2017-2028)
8.3.2 Asia Pacific mTOR Inhibitors Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Indonesia
8.3.9 Thailand
8.3.10 Malaysia
8.3.11 Philippines
8.3.12 Vietnam
9 Latin America
9.1 Latin America mTOR Inhibitors Market Size by Type
9.1.1 Latin America mTOR Inhibitors Sales by Type (2017-2028)
9.1.2 Latin America mTOR Inhibitors Revenue by Type (2017-2028)
9.2 Latin America mTOR Inhibitors Market Size by Application
9.2.1 Latin America mTOR Inhibitors Sales by Application (2017-2028)
9.2.2 Latin America mTOR Inhibitors Revenue by Application (2017-2028)
9.3 Latin America mTOR Inhibitors Market Size by Country
9.3.1 Latin America mTOR Inhibitors Sales by Country (2017-2028)
9.3.2 Latin America mTOR Inhibitors Revenue by Country (2017-2028)
9.3.3 Brazil
10 Middle East and Africa
10.1 Middle East and Africa mTOR Inhibitors Market Size by Type
10.1.1 Middle East and Africa mTOR Inhibitors Sales by Type (2017-2028)
10.1.2 Middle East and Africa mTOR Inhibitors Revenue by Type (2017-2028)
10.2 Middle East and Africa mTOR Inhibitors Market Size by Application
10.2.1 Middle East and Africa mTOR Inhibitors Sales by Application (2017-2028)
10.2.2 Middle East and Africa mTOR Inhibitors Revenue by Application (2017-2028)
10.3 Middle East and Africa mTOR Inhibitors Market Size by Country
10.3.1 Middle East and Africa mTOR Inhibitors Sales by Country (2017-2028)
10.3.2 Middle East and Africa mTOR Inhibitors Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 GCC Countries
10.3.6 South Africa
11 Company Profiles
11.1 LC Laboratories
11.1.1 LC Laboratories Corporation Information
11.1.2 LC Laboratories Overview
11.1.3 LC Laboratories mTOR Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 LC Laboratories mTOR Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 LC Laboratories Recent Developments
11.2 Teva Pharmaceutical Industries Ltd.
11.2.1 Teva Pharmaceutical Industries Ltd. Corporation Information
11.2.2 Teva Pharmaceutical Industries Ltd. Overview
11.2.3 Teva Pharmaceutical Industries Ltd. mTOR Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Teva Pharmaceutical Industries Ltd. mTOR Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Pharmaceutical Industries Ltd. Recent Developments
11.3 Exelixis
11.3.1 Exelixis Corporation Information
11.3.2 Exelixis Overview
11.3.3 Exelixis mTOR Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Exelixis mTOR Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Exelixis Recent Developments
11.4 Novartis Oncology
11.4.1 Novartis Oncology Corporation Information
11.4.2 Novartis Oncology Overview
11.4.3 Novartis Oncology mTOR Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Novartis Oncology mTOR Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis Oncology Recent Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Overview
11.5.3 Pfizer mTOR Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Pfizer mTOR Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 GSK
11.6.1 GSK Corporation Information
11.6.2 GSK Overview
11.6.3 GSK mTOR Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 GSK mTOR Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GSK Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 mTOR Inhibitors Industry Chain Analysis
12.2 mTOR Inhibitors Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 mTOR Inhibitors Production Mode & Process
12.4 mTOR Inhibitors Sales and Marketing
12.4.1 mTOR Inhibitors Sales Channels
12.4.2 mTOR Inhibitors Distributors
12.5 mTOR Inhibitors Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 mTOR Inhibitors Industry Trends
13.2 mTOR Inhibitors Market Drivers
13.3 mTOR Inhibitors Market Challenges
13.4 mTOR Inhibitors Market Restraints
14 Key Findings in The Global mTOR Inhibitors Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer